RA Capital Management »

Lexeo Therapeutics shares owned by RA Capital Management

Quarter-by-quarter ownership of Lexeo Therapeutics (LXEO) shares owned by RA Capital Management from 13F filings

Historical chart of RA Capital Management investment in Lexeo Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Lexeo Therapeutics held by RA Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lexeo Therapeutics by RA Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $10M 661k 15.68

More positions owned by RA Capital Management

Ascendis Pharma A/s - SH (ASND)
Vaxcyte SH (PCVX)
Legend Biotech Corp- SH (LEGN)
Janux Therapeutics SH (JANX)
Aerovate Therapeutics SH (AVTE)
Rhythm Pharmaceuticals SH (RYTM)
Evolent Health Inc - A SH (EVH)
Newamsterdam Pharma Co Nv SH (NAMS)
Rxsight SH (RXST)
Tyra Biosciences SH (TYRA)
Edgewise Therapeutics SH (EWTX)
4d Molecular Therapeutics In SH (FDMT)
Biogen SH (BIIB)
Pepgen SH (PEPG)
Geron Corp SH (GERN)

View all positions for RA Capital Management

Top funds holding Lexeo Therapeutics

Eventide Asset Management
Henderson Group
Citadel Advisors
Omega Fund Management
Adage Capital Partners GP
Braidwell
Artal Group
Blackstone Group
BlackRock
RA Capital Management
Millennium Management
Vanguard Group
Laurion Capital Management
Geode Capital Management
Cornell University

View all funds holding Lexeo Therapeutics